| Hans-Günter Meyer-Thompson | international
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada.
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada.
Morin KA, Acharya S, Eibl JK, Marsh DC.
Int J Drug Policy. 2020 Dec 23;90:103088. doi: 10.1016/j.drugpo.2020.103088. Epub ahead of print. PMID: 33385974.